Recombinant MT-ND4L is synthesized using advanced expression systems, ensuring high fidelity to the native protein:
MT-ND4L mutations in humans are linked to Leber hereditary optic neuropathy (LHON) and Leigh syndrome . The recombinant Macaca nigrescens protein enables comparative studies to:
Investigate evolutionary conservation of Complex I dysfunction
Screen therapeutic compounds targeting mitochondrial disorders
Activity Measurement: Quantify NADH dehydrogenase activity via spectrophotometric assays
Protein-Protein Interaction Studies: Map binding interfaces with other Complex I subunits
While derived from non-human primates, human MT-ND4L mutations provide context for its research utility:
MT-ND4L (NADH-ubiquinone oxidoreductase chain 4L) is a core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) that belongs to the minimal assembly required for catalysis. It functions in transferring electrons from NADH to the respiratory chain, with ubiquinone believed to be the immediate electron acceptor . As part of Complex I, MT-ND4L contributes to creating the electrochemical gradient across the inner mitochondrial membrane that drives ATP synthesis through oxidative phosphorylation .
In Macaca nigrescens, MT-ND4L is a small hydrophobic protein consisting of 98 amino acids with a molecular mass of approximately 10.8 kDa . Its hydrophobic nature facilitates its integration into the inner mitochondrial membrane where it performs its electron transport function.
The Macaca nigrescens MT-ND4L protein has several key structural characteristics:
Sequence: MIPTYMNIMLAFTISLLGMLTYRSHLVASLLCLEGMMMSLFIMATLMASNTHFPLINIMPIILLVFAACEAAVGLALLISISNTYGLDYIHNLNLLQC
| Amino Acid Type | Percentage | Functional Significance |
|---|---|---|
| Hydrophobic (A,I,L,M,F,V,W,Y) | ~61% | Membrane integration |
| Polar uncharged (N,C,Q,S,T) | ~18% | Protein folding and stability |
| Charged (D,E,H,K,R) | ~8% | Potential interaction sites |
| Special cases (G,P) | ~13% | Structural flexibility |
The highly hydrophobic character of MT-ND4L is essential for its integration into the mitochondrial membrane and proper functioning within Complex I .
The MT-ND4L gene is encoded in the mitochondrial genome, which is maternally inherited and has distinct evolutionary patterns compared to nuclear DNA . Several notable aspects of MT-ND4L gene organization include:
In some organisms like Neurospora crassa, the ND4L gene contains intervening sequences (introns) .
A distinctive feature in many species is that the stop codon of the ND4L gene overlaps with the initiation codon of the downstream ND5 gene .
The genes are often cotranscribed and probably cotranslated, as demonstrated by the detection of mature dicistronic (ND4L plus ND5) RNA .
In N. crassa, the postulated mRNA (about 3.2 kb) contains 5' and 3' non-coding regions of about 86 and 730 nucleotides, respectively .
This compact genomic organization highlights the efficiency of mitochondrial gene arrangement and expression.
MT-ND4L shows varying degrees of conservation across species, reflecting its essential role in cellular energy production. For example:
The Neurospora crassa ND4L protein shares about 26% homology with the human mitochondrial protein (increasing to 41% if conservative amino acid substitutions are considered) .
Within macaque species, there is high conservation, with very little intraspecific variation observed between different M. nigrescens samples .
The conservation pattern suggests strong functional constraints due to the protein's critical role in oxidative phosphorylation.
The study of MT-ND4L sequences across different macaque species contributes to understanding evolutionary relationships and mitochondrial adaptation. Mitogenomic studies using MT-ND4L and other mitochondrial genes have provided insights into macaque dispersal across Wallace's Line and phylogenetic relationships among Sulawesi macaques .
Production of recombinant MT-ND4L requires specialized approaches due to its hydrophobic nature:
Expression systems: E. coli expression systems are commonly used, with protein synthesis services available starting at $99 plus $.30/amino acid with turnaround times as fast as two weeks .
Optimization strategies:
Codon optimization for the expression host
Use of solubility-enhancing fusion tags
Expression in specialized strains designed for membrane proteins
Careful control of expression conditions (temperature, inducer concentration)
Purification approach:
Detergent solubilization from membrane fractions
Affinity chromatography utilizing fusion tags
Size exclusion chromatography for final purification
Quality control:
Validating functional integrity of recombinant MT-ND4L involves multiple complementary approaches:
Structural integrity assessment:
Circular dichroism to analyze secondary structure composition
Limited proteolysis to verify proper folding
Thermal stability assays to determine melting temperature
Functional assays:
NADH oxidation activity measurements
Ubiquinone reduction assays
Membrane potential measurements in reconstituted systems
Complex I assembly analysis:
Co-immunoprecipitation with other Complex I subunits
Blue native PAGE to assess incorporation into higher-order complexes
Electron microscopy to visualize complex formation
Cellular complementation:
Rescue experiments in cells with MT-ND4L deficiency
Oxygen consumption rate measurements using Seahorse analyzer
ATP production capacity assessment
Comparative analysis of MT-ND4L across macaque species reveals important evolutionary patterns:
Notably, M. nigra and M. nigrescens have a strongly supported sister relationship based on nuclear DNA and are distributed in parapatry on the distal end of the northern peninsula of Sulawesi . Despite their close geographic distribution, the mitochondrial genome shows some divergence between these species.
Mitogenomic studies have revealed that very little intraspecific variation exists between the two M. nigrescens samples that have been analyzed, suggesting strong selective pressure to maintain the functional properties of this protein .
Purifying and maintaining stability of recombinant MT-ND4L presents several challenges:
Membrane protein solubilization:
Selection of appropriate detergents is critical
Concentration balance between sufficient solubilization and protein denaturation
Potential loss of native lipid interactions
Aggregation prevention:
Hydrophobic nature promotes aggregation during purification
Need for stabilizing agents (glycerol, specific lipids)
Temperature control throughout purification process
Structural integrity maintenance:
Difficulty maintaining native conformation outside membrane environment
Potential requirement for specific lipids or partner proteins
Vulnerability to oxidation due to cysteine residues
Functional assessment limitations:
MT-ND4L functions as part of a large complex
Individual activity difficult to measure in isolation
Requires reconstitution with other subunits
Recombination in mitochondrial genes, including MT-ND4L, has been a subject of investigation:
This suggests that while recombination in mitochondrial DNA is possible, strong evidence for recombination in M. nigrescens MT-ND4L is currently lacking.
MT-ND4L can serve as a valuable tool for investigating Complex I assembly through several experimental approaches:
Fluorescently tagged MT-ND4L tracking:
Real-time monitoring of assembly process
Spatial and temporal dynamics of complex formation
Identification of assembly intermediates
Mutational analysis:
Systematic mutation of key residues
Assessment of impact on complex formation
Identification of critical interaction domains
Protein-protein interaction studies:
Co-immunoprecipitation with other Complex I subunits
Proximity labeling techniques (BioID, APEX)
Cross-linking coupled with mass spectrometry
Time-resolved assembly monitoring:
Pulse-chase experiments with labeled MT-ND4L
Sequential isolation of assembly intermediates
Kinetic analysis of complex formation
Several pathogenic mutations in MT-ND4L have been identified with various molecular consequences:
The T10663C (Val65Ala) mutation has been identified in several families with Leber hereditary optic neuropathy . This mutation changes the valine at position 65 to alanine in the NADH dehydrogenase 4L protein .
Disruption of the electron transport process in Complex I
Increased production of reactive oxygen species
Altered complex assembly or stability
Compromised energy production in retinal ganglion cells
Advanced imaging techniques offer powerful approaches to study MT-ND4L incorporation:
Super-resolution microscopy:
STED (Stimulated Emission Depletion) microscopy
PALM (Photoactivated Localization Microscopy)
STORM (Stochastic Optical Reconstruction Microscopy)
Resolution beyond the diffraction limit (~20-50 nm)
Visualization of protein distribution within mitochondrial subcompartments
Live-cell imaging:
Single-particle tracking of fluorescently labeled MT-ND4L
FRAP (Fluorescence Recovery After Photobleaching) to measure mobility
FRET (Förster Resonance Energy Transfer) to detect protein-protein interactions
Real-time monitoring of assembly process
Correlative approaches:
CLEM (Correlative Light and Electron Microscopy)
Combines molecular specificity of fluorescence with ultrastructural detail
Precise localization within mitochondrial cristae structure
Experimental workflow:
Express fluorescently tagged recombinant MT-ND4L
Import tracking into isolated mitochondria or living cells
Time-lapse imaging of incorporation process
Quantitative analysis of spatial distribution and kinetics
Several methodological approaches can elucidate MT-ND4L interactions:
Cross-linking coupled with mass spectrometry (XL-MS):
Chemical cross-linking of interacting proteins
Digestion and identification of cross-linked peptides
Mapping of interaction interfaces at amino acid resolution
Proximity labeling:
BioID or APEX2 fusion to MT-ND4L
Labeling of proximal proteins in native environment
Identification of interaction landscape by mass spectrometry
Co-immunoprecipitation and pulldown assays:
Antibody-based isolation of MT-ND4L complexes
Tag-based purification (His, FLAG, etc.)
Western blot or mass spectrometry identification of binding partners
Cryo-electron microscopy:
High-resolution structural determination
Visualization of MT-ND4L position within Complex I
Identification of specific interaction interfaces
Hydrogen-deuterium exchange mass spectrometry (HDX-MS):
Detection of solvent-accessible regions
Identification of protected interfaces upon complex formation
Dynamic analysis of interaction landscape
MT-ND4L offers several approaches for modeling mitochondrial diseases:
Cell-based models:
Introduction of mutant MT-ND4L into cybrid cell lines
CRISPR-based mitochondrial genome editing
Patient-derived cells carrying MT-ND4L mutations
Assessment of bioenergetic parameters, ROS production, and cell viability
Biochemical reconstitution:
In vitro assembly of Complex I with wild-type or mutant MT-ND4L
Functional assessment of electron transfer activity
Structural analysis of assembled complexes
Animal models:
Introduction of mutant MT-ND4L into model organisms
Analysis of tissue-specific phenotypes
Preclinical testing of potential therapies
Drug screening platforms:
High-throughput screens using cells with MT-ND4L defects
Identification of compounds that rescue mitochondrial function
Development of targeted therapies for MT-ND4L-related diseases
Future research directions for MT-ND4L include:
Structural biology advances:
High-resolution structures of MT-ND4L within Complex I
Molecular dynamics simulations of mutation effects
Structure-based drug design targeting MT-ND4L interfaces
Gene therapy approaches:
Mitochondrially targeted nucleases for mutation correction
Allotopic expression of MT-ND4L from the nuclear genome
RNA-based therapies to suppress mutant mtDNA
Systems biology integration:
Multi-omics analysis of MT-ND4L mutations
Network-based approaches to understand disease mechanisms
Computational modeling of MT-ND4L's role in mitochondrial function
Precision medicine applications:
Biomarker development for MT-ND4L-related diseases
Patient stratification based on molecular profiles
Personalized therapeutic approaches for specific mutations
Evolutionary medicine perspectives:
Comparative analysis across species to identify critical functional domains
Natural selection patterns to understand disease vulnerability
Ancestral sequence reconstruction to identify stabilizing mutations